ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 629868 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 629868; 2) Community: the network communities that were significantly associated with the response to NSC 629868; 3) Molecule: the relationships between components within communities and NSC 629868; 4) MDR: the compounds that were significantly associated with the NSC 629868.

NSC Compound Enrichment Correlation
NSC 712733 Null 0.0140755620492158 -0.074547257
NSC 728040 2-[4-(methoxy)phenyltio]-3-phenyl-5,7-diamino quinoxaline 0.0140755620492158 -0.24244137
NSC 736081 4-morpholin-4-yl-6[(Z)-2-(5-nitro-thiophen-2-yl)ethenyl]-1,3 ,5-triazin-2-ylamine 0.0140755620492158 -0.1033648
NSC 743244 Null 0.0140755620492158 -0.26277782
NSC 743432 2-{5-[4-(5-{4-[6-morpholino-1H-benzo[d]imidazole-2-yl]phenoxy}pentyl)piperazino]pentyl}-2,3-dihydro-1H-benzo[de]isoquinoline-1,3-dione 0.0140755620492158 -0.29561677
NSC 743556 Null 0.0140755620492158 -0.060429519
NSC 99027 Null 0.0140755620492158 -0.22621169
NSC 621888 Cyclopentanone, 2-[(dimethylamino)methyl]-, hydrochloride (9CI) 0.0152653588725065 -0.29890682
NSC 668261 Null 0.0152653588725065 -0.25832632
NSC 735181 (1,1-dioxido-3-oxo-1,2-benzisothiazol-2(3H)-yl)methyl 4-methylpiperazine-1-carbodithioate 0.0152653588725065 -0.32453461
Total:116  Current:52    [First] [Prev] [Next] [Last]